These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 37513917)

  • 1. Retraction Note: MiRNA-27a mediates insulin resistance in 3T3-L1 cells through the PPARγ.
    Zhuang Y; Li M
    Mol Cell Biochem; 2023 Dec; 478(12):2917. PubMed ID: 37378801
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid Nanoparticles as a Shuttle for Anti-Adipogenic miRNAs to Human Adipocytes.
    Schachner-Nedherer AL; Fuchs J; Vidakovic I; Höller O; Schratter G; Almer G; Fröhlich E; Zimmer A; Wabitsch M; Kornmueller K; Prassl R
    Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug design strategies that aim to improve the low solubility and poor bioavailability conundrum in quercetin derivatives.
    Alizadeh SR; Savadkouhi N; Ebrahimzadeh MA
    Expert Opin Drug Discov; 2023; 18(10):1117-1132. PubMed ID: 37515777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and Optimization of MiR-375 Nano-Vector Using Two Novel Chitosan-Coated Nano-Structured Lipid Carriers as Gene Therapy for Hepatocellular Carcinoma.
    Soliman B; Wen MM; Kandil E; El-Agamy B; Gamal-Eldeen AM; ElHefnawi M
    Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipogenic miRNA and meta-signature miRNAs involved in human adipocyte differentiation and obesity.
    Shi C; Huang F; Gu X; Zhang M; Wen J; Wang X; You L; Cui X; Ji C; Guo X
    Oncotarget; 2016 Jun; 7(26):40830-40845. PubMed ID: 27049726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Characterization of Cationic Nanostructured Lipid Carriers as Drug Delivery Systems for miRNA-27a.
    Tucak-Smajić A; Ruseska I; Letofsky-Papst I; Vranić E; Zimmer A
    Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological Activity Of miRNA-27a Using Peptide-based Drug Delivery Systems.
    Schachner-Nedherer AL; Werzer O; Kornmueller K; Prassl R; Zimmer A
    Int J Nanomedicine; 2019; 14():7795-7808. PubMed ID: 31576124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular uptake and trafficking of peptide-based drug delivery systems for miRNA.
    Ruseska I; Zimmer A
    Eur J Pharm Biopharm; 2023 Oct; 191():189-204. PubMed ID: 37666365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A promising approach to develop nanostructured lipid carriers from solid lipid nanoparticles: preparation, characterization, cytotoxicity and nucleic acid binding ability.
    Oner E; Kotmakci M; Kantarci AG
    Pharm Dev Technol; 2020 Oct; 25(8):936-948. PubMed ID: 32315242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and biodistribution in vivo of quercetin-loaded cationic nanostructured lipid carriers.
    Liu L; Tang Y; Gao C; Li Y; Chen S; Xiong T; Li J; Du M; Gong Z; Chen H; Liu L; Yao P
    Colloids Surf B Biointerfaces; 2014 Mar; 115():125-31. PubMed ID: 24333909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-23a regulates 3T3-L1 adipocyte differentiation.
    Shen L; Zhang Y; Du J; Chen L; Luo J; Li X; Li M; Tang G; Zhang S; Zhu L
    Gene; 2016 Jan; 575(2 Pt 3):761-4. PubMed ID: 26415879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of lipid-based nanoparticles for delivery of therapeutic nucleic acids.
    Mendonça MCP; Kont A; Kowalski PS; O'Driscoll CM
    Drug Discov Today; 2023 Mar; 28(3):103505. PubMed ID: 36708760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid nanoparticles in the development of mRNA vaccines for COVID-19.
    Wilson B; Geetha KM
    J Drug Deliv Sci Technol; 2022 Aug; 74():103553. PubMed ID: 35783677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleic Acid-Loaded Lipid Nanoparticle Interactions with Model Endosomal Membranes.
    Spadea A; Jackman M; Cui L; Pereira S; Lawrence MJ; Campbell RA; Ashford M
    ACS Appl Mater Interfaces; 2022 Jul; 14(26):30371-30384. PubMed ID: 35758331
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.